AngioDynamics Q3 Adj. EPS $(0.07) Beats $(0.11) Estimate, Sales $78.423M Beat $76.767M Estimate

AngioDynamics reported Q3 adjusted earnings per share of $(0.07), surpassing the analyst estimate of $(0.11) by 36.36%. This reflects a 12.5% increase in losses compared to $(0.08) per share from the same period last year. The company's quarterly sales reached $78.423 million, exceeding the $76.767 million estimate by 2.16% and marking an 8.91% increase from $72.004 million in the prior year.